Thank you. I just want to clear up one thing. We're not actually doing research. The facility is focused on production, so what we're going to be doing is helping to put to market drugs that the private sector right now can't on its own, either because there is a high risk of failure or because there's a lack of profitability. That was the example I brought in terms of orphan drugs for rare diseases.
On May 17th, 2021. See this statement in context.